These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7169949)

  • 21. Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy Group.
    Spittle MF; Bates TD; Kitchen G; Nicol NT; Wheeler T; Edelstyn G; MacRae KD; Ostrowski MJ
    Clin Oncol; 1980 Jun; 6(2):153-7. PubMed ID: 7408282
    [No Abstract]   [Full Text] [Related]  

  • 22. Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinoma.
    Mikhak B; Zahurak M; Abeloff MD; Fetting JH; Davidson NE; Donehower RC; Waterfield W; Kennedy MJ
    Cancer; 1999 Feb; 85(4):899-904. PubMed ID: 10091768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intra-arterial infusion chemotherapy with adriamycin for the treatment of locally advanced breast cancer--studies of serum and tissue concentrations of adriamycin].
    Takatsuka Y; Imamotoh H; Tsuchiyama M; Numata N; Kawahara T
    Gan To Kagaku Ryoho; 1982 May; 9(5):880-7. PubMed ID: 7184432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancer.
    Dombernowsky P; Gehl J; Boesgaard M; Paaske T; Jensen BV
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):23-7. PubMed ID: 8893895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of refractory metastatic breast cancer with 5-fluorouracil plus levofolinic acid as continuous venous infusion: a phase II study.
    Gebbia V; Borsellino N; Testa A; Tirrito M; Varvara F; Cucchiara A; Mauceri G; Girlando A; Ferrara M; Caruso F
    Anticancer Res; 1999; 19(4C):3553-7. PubMed ID: 10629652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)].
    Michlmayr G; Kratzer H; Denz H; Huber H
    Wien Klin Wochenschr; 1981 Mar; 93(6):205-7. PubMed ID: 7281697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.
    Hsu C; Huang CS; Chao TY; Lu YS; Bu CF; Chen MM; Chang KJ; Cheng AL
    Cancer; 2002 Nov; 95(10):2044-50. PubMed ID: 12412156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A comparative study of 4 sequential first-line chemotherapy protocols in locally advanced breast cancer].
    Ferrero JM; Namer M; Dufour JF; Largillier R; Creisson A; Teissier E; Machiavello JC; Lallement M; Monticelli J; Abbes M
    Bull Cancer; 1997 Jan; 84(1):10-6. PubMed ID: 9180853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paclitaxel (Taxol)/doxorubicin combinations in advanced breast cancer: the Eastern Cooperative Oncology Group experience.
    Sledge GW; Robert N; Sparano JA; Cobeligh M; Goldstein LJ; Neuberg D; Rowinsky E; Baughman C; McCaskill-Stevens W
    Semin Oncol; 1994 Oct; 21(5 Suppl 8):15-8. PubMed ID: 7939756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monochemotherapy (Adriamycin) for metastatic breast cancer in progression after sequential hormone-chemotherapy (MAP and CMF). Pilot study.
    Pannuti F; Rossi AP; Di Marco AR; Fruet F; Lelli G; Strocchi E; Rocchetta G; Piana E; Martoni A
    Panminerva Med; 1981; 23(1):25-8. PubMed ID: 7290722
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response.
    Cameron DA; Gregory WM; Bowman A; Anderson ED; Levack P; Forouhi P; Leonard RC
    Br J Cancer; 2000 Jul; 83(1):98-103. PubMed ID: 10883676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic action of vincristine and adriamycin in the treatment of experimental rat leukemia L5222.
    Zeller WJ; Berger M; Schmähl D
    Cancer Res; 1979 Mar; 39(3):1071-3. PubMed ID: 427748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of the therapeutic effect of CMxMF and CAMF regimens in the management of advanced breast cancer patients].
    Chen JA
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):202-4. PubMed ID: 8261866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patients with advanced breast carcinoma.
    Zimmerman TM; Grinblatt DL; Malloy R; Williams SF
    Cancer; 1998 Oct; 83(8):1540-5. PubMed ID: 9781947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of "split" courses of combination chemotherapy in breast cancer].
    Dymarskiĭ LIu; Aleksandrova GI; Sanchakova AV
    Vopr Onkol; 1981; 27(7):82-5. PubMed ID: 7269435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lower cardiotoxicity of adriamycin during continuous administration in patients with refractory multiple myeloma treated with cyclophosphamide, vincristine, adriamycin and dexamethasone (C-VAD)].
    Adam Z; Elbl L; Vorlícek J; Hájek R; Tomíska M; Hejlová N; Králová E; Novotná H
    Vnitr Lek; 1994 Aug; 40(8):506-12. PubMed ID: 7941437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of implantable injection port for advanced breast cancer patients].
    Nakamura S; Itoh M; Ohigashi S; Nishio T; Abe O; Sakurai K
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1529-32. PubMed ID: 8854798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chemo-endocrine therapy including mitomycin C and medroxyprogesterone acetate in doxorubicin-refractory advanced breast cancer].
    Nomura Y; Tashiro H; Shirouzu M; Takayama T
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):439-45. PubMed ID: 8678495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Results of "5-drug" treatment of advanced breast cancer].
    Dorociak R
    Pol Tyg Lek; 1981 Sep; 36(38):1467-70. PubMed ID: 7329862
    [No Abstract]   [Full Text] [Related]  

  • 40. [Adriamycin/cyclophosphamide: current standard in the adjuvant therapy of breast carcinoma? Or: how should one really put this question?].
    Cavalli F
    Schweiz Med Wochenschr; 1994 Oct; 124(43):1882-4. PubMed ID: 7973514
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.